NCT07150598View on ClinicalTrials.gov

Immune-Marker Platform for Patients With Advanced Lung Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

June 1, 2027

Conditions
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC Stage IIIB~IVNSCLC Non-small Cell Lung Cancer
Trial Locations (2)

50937

Universitätsklinikum Köln, Centrum für Integrierte Onkologie (CIO) Köln, Cologne

01307

Universitätsklinikum Carl Gustav Carus, Dresden

All Listed Sponsors
collaborator

Deutsche Krebshilfe e.V., Bonn (Germany)

OTHER

collaborator

Universitätsklinikum Köln

OTHER

lead

Technische Universität Dresden

OTHER